Native rhIGF-1 in IGF-1 Deficiency Chernausek et al., Journal of Clinical Endocrinology & Metabolism (2007) Chernausek and colleagues conducted the pivotal long-term clinical trial of recombinant human IGF-1 (mecasermin) in pediatric patients with severe primary IGF-1 deficiency the trial that supported FDA approval of Increlex for this rare growth-failure population
GHK-Cu (Copper Peptide) Your skins secret weapon for repair, regeneration, and glow Meet GHK-Cu (Copper Peptide) one of the most powerful peptides in aesthetics and wellness
One cohort study reported no statistically significant association between metformin treatment and OA occurrence in patients with type 2 diabetes (Fig
Future prospects Today, the available pharmacological arsenal includes approaches to emerging conditions such as peripheral arterial disease and neurodegenerative disorders, further reinforcing the role of metabolic diseases in the pathophysiology of various conditions that have a profound impact on both quality of life and life expectancy in the population.60 Advances in knowledge and biochemical engineering are paving the way for intervention at multiple levels in the prevention and treatment of various complications, while also promoting therapeutic individualisation
Stem Cells (2018) 36(7):9901003
So, for example, if you made a change and then something improved, look at everything that changed and were they all overlapping, in which case it's kind of hard to figure out what it is, or is there a distinct association, time-wise, between something changing and something improving